In-process controls and characterization of recombinate antihemophilic factor (recombinant).
Baxter Hyland Division, Duarte, CA 91010.
M
M
Griffith
H
H
Kingdon
S L
SL
Liu
W
W
Burkart
D000911:Antibodies, Monoclonal; D001665:Binding Sites; D002846:Chromatography, Affinity; D002851:Chromatography, High Pressure Liquid; D004340:Drug Contamination / Q000517:prevention & control; D005169:Factor VIII / Q000737:chemistry / Q000302:isolation & purification / Q000627:therapeutic use; D006031:Glycosylation; D006801:Humans; D015394:Molecular Structure; D008970:Molecular Weight; D011994:Recombinant Proteins / Q000737:chemistry / Q000302:isolation & purification / Q000627:therapeutic use; D013917:Thrombin / Q000378:metabolism; D014841:von Willebrand Factor / Q000032:analysis
D000911:Antibodies, Monoclonal; D011994:Recombinant Proteins; D014841:von Willebrand Factor; D005169:Factor VIII; D013917:Thrombin